Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Matthew Glover, Erin Montague, Alexandra Pollitt, Susan Guthrie, Stephen Hanney, Martin Buxton, Jonathan Grant

ABSTRACT

BACKGROUND: Building on an approach applied to cardiovascular and cancer research, we estimated the economic returns from United Kingdom public- and charitable-funded musculoskeletal disease (MSD) research that arise from the net value of the improved health outcomes in the United Kingdom. METHODS: To calculate the economic returns from MSD-related research in the United Kingdom, we estimated (1) the public and charitable expenditure on MSD-related research in the United Kingdom between 1970 and 2013; (2) the net monetary benefit (NMB), derived from the health benefit in quality adjusted life years (QALYs) valued in monetary terms (using a base-case value of a QALY of £25,000) minus the cost of delivering that benefit, for a prioritised list of interventions from 1994 to 2013; (3) the proportion of NMB attributable to United Kingdom research; and (4) the elapsed time between research funding and health gain. The data collected from these four key elements were used to estimate the internal rate of return (IRR) from MSD-related research investments on health benefits. We analysed the uncertainties in the IRR estimate using a one-way sensitivity analysis. RESULTS: Expressed in 2013 prices, total expenditure on MSD-related research from 1970 to 2013 was £3.5 billion, and for the period used to estimate the rate of return, 1978-1997, was £1.4 billion. Over the period 1994-2013 the key interventions analysed produced 871,000 QALYs with a NMB of £16 billion, allowing for the net NHS costs resulting from them and valuing a QALY at £25,000. The proportion of benefit attributable to United Kingdom research was 30% and the elapsed time between funding and impact of MSD treatments was 16 years. Our best estimate of the IRR from MSD-related research was 7%, which is similar to the 9% for CVD and 10% for cancer research. CONCLUSIONS: Our estimate of the IRR from the net health gain to public and charitable funding of MSD-related research in the United Kingdom is substantial, and justifies the research investments made between 1978 and 1997. We also demonstrated the applicability of the approach previously used in assessing the returns from cardiovascular and cancer research. Inevitably, with a study of this kind, there are a number of important assumptions and caveats that we highlight, and these can inform future research. More... »

PAGES

1

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12961-017-0276-7

DOI

http://dx.doi.org/10.1186/s12961-017-0276-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1100279434

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29316935


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomedical Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Charities", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Financing, Government", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Care Costs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Musculoskeletal Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality-Adjusted Life Years", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "State Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Translational Medical Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Brunel University London", 
          "id": "https://www.grid.ac/institutes/grid.7728.a", 
          "name": [
            "Health Economics Research Group, Brunel University London, Uxbridge, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Glover", 
        "givenName": "Matthew", 
        "id": "sg:person.01137153570.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137153570.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Policy Institute at King\u2019s, King\u2019s College London, Virginia Woolf Building, 22 Kingsway, WC2B 6LE, London, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montague", 
        "givenName": "Erin", 
        "id": "sg:person.016065276306.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016065276306.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Policy Institute at King\u2019s, King\u2019s College London, Virginia Woolf Building, 22 Kingsway, WC2B 6LE, London, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pollitt", 
        "givenName": "Alexandra", 
        "id": "sg:person.01335400150.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335400150.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RAND Europe", 
          "id": "https://www.grid.ac/institutes/grid.425785.9", 
          "name": [
            "RAND Europe, Cambridge, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guthrie", 
        "givenName": "Susan", 
        "id": "sg:person.01052724140.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052724140.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brunel University London", 
          "id": "https://www.grid.ac/institutes/grid.7728.a", 
          "name": [
            "Health Economics Research Group, Brunel University London, Uxbridge, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hanney", 
        "givenName": "Stephen", 
        "id": "sg:person.01236410736.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236410736.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brunel University London", 
          "id": "https://www.grid.ac/institutes/grid.7728.a", 
          "name": [
            "Health Economics Research Group, Brunel University London, Uxbridge, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buxton", 
        "givenName": "Martin", 
        "id": "sg:person.01123604615.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123604615.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Policy Institute at King\u2019s, King\u2019s College London, Virginia Woolf Building, 22 Kingsway, WC2B 6LE, London, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grant", 
        "givenName": "Jonathan", 
        "id": "sg:person.01055471415.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40273-013-0052-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000299188", 
          "https://doi.org/10.1007/s40273-013-0052-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61046-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003715721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1741-7015-12-99", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006565540", 
          "https://doi.org/10.1186/1741-7015-12-99"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keh708", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008752227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keh708", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008752227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/09638280600841471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009758764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.320.7242.1107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010284812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12961-015-0074-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010626359", 
          "https://doi.org/10.1186/s12961-015-0074-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12916-016-0564-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011671285", 
          "https://doi.org/10.1186/s12916-016-0564-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00264-013-1829-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016627488", 
          "https://doi.org/10.1007/s00264-013-1829-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/jrsm.2011.110180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020182210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/jrsm.2011.110180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020182210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)60355-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021176069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.f1026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027477443"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1098/rspa.1975.0137", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028470339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.109.904235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031265508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/kem054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034771761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10198-013-0486-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038066898", 
          "https://doi.org/10.1007/s10198-013-0486-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1361-3111(02)00055-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039663899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1361-3111(02)00055-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039663899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2012-202634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040557704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.38282.669225.ae", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044623132"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keh512", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045502678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1478-4505-13-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046498955", 
          "https://doi.org/10.1186/1478-4505-13-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.11138/mltj/2013.3.2.063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062064082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta12260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta15100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta15140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta19140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta20090", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139564"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta20340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta20350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta20760", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta9220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3899/jrheum.101327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071542484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076621948", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076992046", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079391281", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12891-017-1428-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083523790", 
          "https://doi.org/10.1186/s12891-017-1428-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12891-017-1428-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083523790", 
          "https://doi.org/10.1186/s12891-017-1428-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Building on an approach applied to cardiovascular and cancer research, we estimated the economic returns from United Kingdom public- and charitable-funded musculoskeletal disease (MSD) research that arise from the net value of the improved health outcomes in the United Kingdom.\nMETHODS: To calculate the economic returns from MSD-related research in the United Kingdom, we estimated (1) the public and charitable expenditure on MSD-related research in the United Kingdom between 1970 and 2013; (2) the net monetary benefit (NMB), derived from the health benefit in quality adjusted life years (QALYs) valued in monetary terms (using a base-case value of a QALY of \u00a325,000) minus the cost of delivering that benefit, for a prioritised list of interventions from 1994 to 2013; (3) the proportion of NMB attributable to United Kingdom research; and (4) the elapsed time between research funding and health gain. The data collected from these four key elements were used to estimate the internal rate of return (IRR) from MSD-related research investments on health benefits. We analysed the uncertainties in the IRR estimate using a one-way sensitivity analysis.\nRESULTS: Expressed in 2013 prices, total expenditure on MSD-related research from 1970 to 2013 was \u00a33.5 billion, and for the period used to estimate the rate of return, 1978-1997, was \u00a31.4 billion. Over the period 1994-2013 the key interventions analysed produced 871,000 QALYs with a NMB of \u00a316 billion, allowing for the net NHS costs resulting from them and valuing a QALY at \u00a325,000. The proportion of benefit attributable to United Kingdom research was 30% and the elapsed time between funding and impact of MSD treatments was 16\u00a0years. Our best estimate of the IRR from MSD-related research was 7%, which is similar to the 9% for CVD and 10% for cancer research.\nCONCLUSIONS: Our estimate of the IRR from the net health gain to public and charitable funding of MSD-related research in the United Kingdom is substantial, and justifies the research investments made between 1978 and 1997. We also demonstrated the applicability of the approach previously used in assessing the returns from cardiovascular and cancer research. Inevitably, with a study of this kind, there are a number of important assumptions and caveats that we highlight, and these can inform future research.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12961-017-0276-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032049", 
        "issn": [
          "1478-4505"
        ], 
        "name": "Health Research Policy and Systems", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes", 
    "pagination": "1", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "51029ab96d72e3330cce9d4efbe89f018f531f52914c41c768a09cc5ea0459ca"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29316935"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101170481"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12961-017-0276-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1100279434"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12961-017-0276-7", 
      "https://app.dimensions.ai/details/publication/pub.1100279434"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000493.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186/s12961-017-0276-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12961-017-0276-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12961-017-0276-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12961-017-0276-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12961-017-0276-7'


 

This table displays all metadata directly associated to this object as RDF triples.

277 TRIPLES      21 PREDICATES      77 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12961-017-0276-7 schema:about N00533e9d7dbb428d9e5a8c453b59f9fc
2 N0bf37ee7a7234f66a9b48b6005a576f4
3 N0eeedf998b124520bb0f1be608459f5a
4 N19e0d679ffc1451cbb9258761ff66ab4
5 N3ef0996dcdcd4377a76e86a33d923f84
6 N6767b8a3113a404b918ed163c19ab51a
7 N7ef51a01b99d46a3989b37f077330326
8 N8ea79c9dcbcb4601bd6138b190f5809e
9 N97a7d31d886b41eda3140a28b8748292
10 Na7d2c5aa13fb453891fc8ca5c0763c0d
11 Nb0c391123af8468e84f7555ce0df7660
12 Nf46b7557c6d04fb58b1d16c21e4dd896
13 anzsrc-for:14
14 anzsrc-for:1402
15 schema:author N639aeb77e526441a8db7343c6d087ac6
16 schema:citation sg:pub.10.1007/s00264-013-1829-1
17 sg:pub.10.1007/s10198-013-0486-z
18 sg:pub.10.1007/s40273-013-0052-7
19 sg:pub.10.1186/1478-4505-13-1
20 sg:pub.10.1186/1741-7015-12-99
21 sg:pub.10.1186/s12891-017-1428-1
22 sg:pub.10.1186/s12916-016-0564-z
23 sg:pub.10.1186/s12961-015-0074-z
24 https://app.dimensions.ai/details/publication/pub.1076621948
25 https://app.dimensions.ai/details/publication/pub.1076992046
26 https://app.dimensions.ai/details/publication/pub.1079391281
27 https://doi.org/10.1016/s0140-6736(13)60355-4
28 https://doi.org/10.1016/s0140-6736(13)61046-6
29 https://doi.org/10.1016/s1361-3111(02)00055-9
30 https://doi.org/10.1080/09638280600841471
31 https://doi.org/10.1093/rheumatology/keh512
32 https://doi.org/10.1093/rheumatology/keh708
33 https://doi.org/10.1093/rheumatology/kem054
34 https://doi.org/10.1098/rspa.1975.0137
35 https://doi.org/10.11138/mltj/2013.3.2.063
36 https://doi.org/10.1136/annrheumdis-2012-202634
37 https://doi.org/10.1136/bmj.320.7242.1107
38 https://doi.org/10.1136/bmj.38282.669225.ae
39 https://doi.org/10.1136/bmj.f1026
40 https://doi.org/10.1161/circulationaha.109.904235
41 https://doi.org/10.1258/jrsm.2011.110180
42 https://doi.org/10.3310/hta12260
43 https://doi.org/10.3310/hta15100
44 https://doi.org/10.3310/hta15140
45 https://doi.org/10.3310/hta19140
46 https://doi.org/10.3310/hta20090
47 https://doi.org/10.3310/hta20340
48 https://doi.org/10.3310/hta20350
49 https://doi.org/10.3310/hta20760
50 https://doi.org/10.3310/hta9220
51 https://doi.org/10.3899/jrheum.101327
52 schema:datePublished 2018-12
53 schema:datePublishedReg 2018-12-01
54 schema:description BACKGROUND: Building on an approach applied to cardiovascular and cancer research, we estimated the economic returns from United Kingdom public- and charitable-funded musculoskeletal disease (MSD) research that arise from the net value of the improved health outcomes in the United Kingdom. METHODS: To calculate the economic returns from MSD-related research in the United Kingdom, we estimated (1) the public and charitable expenditure on MSD-related research in the United Kingdom between 1970 and 2013; (2) the net monetary benefit (NMB), derived from the health benefit in quality adjusted life years (QALYs) valued in monetary terms (using a base-case value of a QALY of £25,000) minus the cost of delivering that benefit, for a prioritised list of interventions from 1994 to 2013; (3) the proportion of NMB attributable to United Kingdom research; and (4) the elapsed time between research funding and health gain. The data collected from these four key elements were used to estimate the internal rate of return (IRR) from MSD-related research investments on health benefits. We analysed the uncertainties in the IRR estimate using a one-way sensitivity analysis. RESULTS: Expressed in 2013 prices, total expenditure on MSD-related research from 1970 to 2013 was £3.5 billion, and for the period used to estimate the rate of return, 1978-1997, was £1.4 billion. Over the period 1994-2013 the key interventions analysed produced 871,000 QALYs with a NMB of £16 billion, allowing for the net NHS costs resulting from them and valuing a QALY at £25,000. The proportion of benefit attributable to United Kingdom research was 30% and the elapsed time between funding and impact of MSD treatments was 16 years. Our best estimate of the IRR from MSD-related research was 7%, which is similar to the 9% for CVD and 10% for cancer research. CONCLUSIONS: Our estimate of the IRR from the net health gain to public and charitable funding of MSD-related research in the United Kingdom is substantial, and justifies the research investments made between 1978 and 1997. We also demonstrated the applicability of the approach previously used in assessing the returns from cardiovascular and cancer research. Inevitably, with a study of this kind, there are a number of important assumptions and caveats that we highlight, and these can inform future research.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf Na457c5850c32429db62dab502f5eb593
59 Ne36f6ec905ad436e93928e4d20850e00
60 sg:journal.1032049
61 schema:name Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes
62 schema:pagination 1
63 schema:productId N12e595de32c649a098c2639f5b492487
64 N4aad486f7aea43c6b88d5d80728bac00
65 N5cc4b5b25eb04f529a6a3d4f04ab7e89
66 N6a4c903d60f145dda5c21e23c6b06efd
67 N8dc405c243e947cdacd49aec04d0595b
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100279434
69 https://doi.org/10.1186/s12961-017-0276-7
70 schema:sdDatePublished 2019-04-11T01:03
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N74b05344c3f649d9a5c42f2bf8a16f86
73 schema:url http://link.springer.com/10.1186/s12961-017-0276-7
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N00533e9d7dbb428d9e5a8c453b59f9fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Quality-Adjusted Life Years
79 rdf:type schema:DefinedTerm
80 N0bf37ee7a7234f66a9b48b6005a576f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Biomedical Research
82 rdf:type schema:DefinedTerm
83 N0eeedf998b124520bb0f1be608459f5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name State Medicine
85 rdf:type schema:DefinedTerm
86 N12e595de32c649a098c2639f5b492487 schema:name dimensions_id
87 schema:value pub.1100279434
88 rdf:type schema:PropertyValue
89 N19e0d679ffc1451cbb9258761ff66ab4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name United Kingdom
91 rdf:type schema:DefinedTerm
92 N1e05711ccba8467a808082732eeab59f rdf:first sg:person.01123604615.70
93 rdf:rest Nc3ba58c44a404291b983f7e142e2cac3
94 N3ef0996dcdcd4377a76e86a33d923f84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Treatment Outcome
96 rdf:type schema:DefinedTerm
97 N4aad486f7aea43c6b88d5d80728bac00 schema:name doi
98 schema:value 10.1186/s12961-017-0276-7
99 rdf:type schema:PropertyValue
100 N5cc4b5b25eb04f529a6a3d4f04ab7e89 schema:name pubmed_id
101 schema:value 29316935
102 rdf:type schema:PropertyValue
103 N639aeb77e526441a8db7343c6d087ac6 rdf:first sg:person.01137153570.55
104 rdf:rest Ncf21fb04f2144d71b4f70de0824cf615
105 N6767b8a3113a404b918ed163c19ab51a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Musculoskeletal Diseases
107 rdf:type schema:DefinedTerm
108 N6a4c903d60f145dda5c21e23c6b06efd schema:name nlm_unique_id
109 schema:value 101170481
110 rdf:type schema:PropertyValue
111 N74b05344c3f649d9a5c42f2bf8a16f86 schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N7ef51a01b99d46a3989b37f077330326 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Health Care Costs
115 rdf:type schema:DefinedTerm
116 N85bf7bf2a8d640189b0e15edbdbd6719 rdf:first sg:person.01335400150.85
117 rdf:rest N8abd04c7245947358c61e6304ab17a9e
118 N8abd04c7245947358c61e6304ab17a9e rdf:first sg:person.01052724140.09
119 rdf:rest Nbbb4dc3170614312bf503249209ec567
120 N8dc405c243e947cdacd49aec04d0595b schema:name readcube_id
121 schema:value 51029ab96d72e3330cce9d4efbe89f018f531f52914c41c768a09cc5ea0459ca
122 rdf:type schema:PropertyValue
123 N8ea79c9dcbcb4601bd6138b190f5809e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 N97a7d31d886b41eda3140a28b8748292 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Cost-Benefit Analysis
128 rdf:type schema:DefinedTerm
129 Na457c5850c32429db62dab502f5eb593 schema:volumeNumber 16
130 rdf:type schema:PublicationVolume
131 Na7d2c5aa13fb453891fc8ca5c0763c0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Translational Medical Research
133 rdf:type schema:DefinedTerm
134 Nb0c391123af8468e84f7555ce0df7660 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Financing, Government
136 rdf:type schema:DefinedTerm
137 Nbbb4dc3170614312bf503249209ec567 rdf:first sg:person.01236410736.55
138 rdf:rest N1e05711ccba8467a808082732eeab59f
139 Nc3ba58c44a404291b983f7e142e2cac3 rdf:first sg:person.01055471415.15
140 rdf:rest rdf:nil
141 Ncf21fb04f2144d71b4f70de0824cf615 rdf:first sg:person.016065276306.12
142 rdf:rest N85bf7bf2a8d640189b0e15edbdbd6719
143 Ne36f6ec905ad436e93928e4d20850e00 schema:issueNumber 1
144 rdf:type schema:PublicationIssue
145 Nf46b7557c6d04fb58b1d16c21e4dd896 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Charities
147 rdf:type schema:DefinedTerm
148 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
149 schema:name Economics
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
152 schema:name Applied Economics
153 rdf:type schema:DefinedTerm
154 sg:journal.1032049 schema:issn 1478-4505
155 schema:name Health Research Policy and Systems
156 rdf:type schema:Periodical
157 sg:person.01052724140.09 schema:affiliation https://www.grid.ac/institutes/grid.425785.9
158 schema:familyName Guthrie
159 schema:givenName Susan
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052724140.09
161 rdf:type schema:Person
162 sg:person.01055471415.15 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
163 schema:familyName Grant
164 schema:givenName Jonathan
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15
166 rdf:type schema:Person
167 sg:person.01123604615.70 schema:affiliation https://www.grid.ac/institutes/grid.7728.a
168 schema:familyName Buxton
169 schema:givenName Martin
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123604615.70
171 rdf:type schema:Person
172 sg:person.01137153570.55 schema:affiliation https://www.grid.ac/institutes/grid.7728.a
173 schema:familyName Glover
174 schema:givenName Matthew
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137153570.55
176 rdf:type schema:Person
177 sg:person.01236410736.55 schema:affiliation https://www.grid.ac/institutes/grid.7728.a
178 schema:familyName Hanney
179 schema:givenName Stephen
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236410736.55
181 rdf:type schema:Person
182 sg:person.01335400150.85 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
183 schema:familyName Pollitt
184 schema:givenName Alexandra
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335400150.85
186 rdf:type schema:Person
187 sg:person.016065276306.12 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
188 schema:familyName Montague
189 schema:givenName Erin
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016065276306.12
191 rdf:type schema:Person
192 sg:pub.10.1007/s00264-013-1829-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016627488
193 https://doi.org/10.1007/s00264-013-1829-1
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/s10198-013-0486-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1038066898
196 https://doi.org/10.1007/s10198-013-0486-z
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/s40273-013-0052-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000299188
199 https://doi.org/10.1007/s40273-013-0052-7
200 rdf:type schema:CreativeWork
201 sg:pub.10.1186/1478-4505-13-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046498955
202 https://doi.org/10.1186/1478-4505-13-1
203 rdf:type schema:CreativeWork
204 sg:pub.10.1186/1741-7015-12-99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006565540
205 https://doi.org/10.1186/1741-7015-12-99
206 rdf:type schema:CreativeWork
207 sg:pub.10.1186/s12891-017-1428-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083523790
208 https://doi.org/10.1186/s12891-017-1428-1
209 rdf:type schema:CreativeWork
210 sg:pub.10.1186/s12916-016-0564-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1011671285
211 https://doi.org/10.1186/s12916-016-0564-z
212 rdf:type schema:CreativeWork
213 sg:pub.10.1186/s12961-015-0074-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1010626359
214 https://doi.org/10.1186/s12961-015-0074-z
215 rdf:type schema:CreativeWork
216 https://app.dimensions.ai/details/publication/pub.1076621948 schema:CreativeWork
217 https://app.dimensions.ai/details/publication/pub.1076992046 schema:CreativeWork
218 https://app.dimensions.ai/details/publication/pub.1079391281 schema:CreativeWork
219 https://doi.org/10.1016/s0140-6736(13)60355-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021176069
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/s0140-6736(13)61046-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003715721
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/s1361-3111(02)00055-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039663899
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1080/09638280600841471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009758764
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1093/rheumatology/keh512 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045502678
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1093/rheumatology/keh708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008752227
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1093/rheumatology/kem054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034771761
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1098/rspa.1975.0137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028470339
234 rdf:type schema:CreativeWork
235 https://doi.org/10.11138/mltj/2013.3.2.063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062064082
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1136/annrheumdis-2012-202634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040557704
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1136/bmj.320.7242.1107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010284812
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1136/bmj.38282.669225.ae schema:sameAs https://app.dimensions.ai/details/publication/pub.1044623132
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1136/bmj.f1026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027477443
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1161/circulationaha.109.904235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031265508
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1258/jrsm.2011.110180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020182210
248 rdf:type schema:CreativeWork
249 https://doi.org/10.3310/hta12260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139030
250 rdf:type schema:CreativeWork
251 https://doi.org/10.3310/hta15100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139223
252 rdf:type schema:CreativeWork
253 https://doi.org/10.3310/hta15140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139227
254 rdf:type schema:CreativeWork
255 https://doi.org/10.3310/hta19140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139470
256 rdf:type schema:CreativeWork
257 https://doi.org/10.3310/hta20090 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139564
258 rdf:type schema:CreativeWork
259 https://doi.org/10.3310/hta20340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139589
260 rdf:type schema:CreativeWork
261 https://doi.org/10.3310/hta20350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139590
262 rdf:type schema:CreativeWork
263 https://doi.org/10.3310/hta20760 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139632
264 rdf:type schema:CreativeWork
265 https://doi.org/10.3310/hta9220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139830
266 rdf:type schema:CreativeWork
267 https://doi.org/10.3899/jrheum.101327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071542484
268 rdf:type schema:CreativeWork
269 https://www.grid.ac/institutes/grid.13097.3c schema:alternateName King's College London
270 schema:name Policy Institute at King’s, King’s College London, Virginia Woolf Building, 22 Kingsway, WC2B 6LE, London, United Kingdom
271 rdf:type schema:Organization
272 https://www.grid.ac/institutes/grid.425785.9 schema:alternateName RAND Europe
273 schema:name RAND Europe, Cambridge, United Kingdom
274 rdf:type schema:Organization
275 https://www.grid.ac/institutes/grid.7728.a schema:alternateName Brunel University London
276 schema:name Health Economics Research Group, Brunel University London, Uxbridge, United Kingdom
277 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...